The Big Bull of Dalal Street How Rakesh Jhunjhunwala Made His Fortune
The Big Bull of Dalal Street How Rakesh Jhunjhunwala Made His Fortune
Neil Borate is deputy editor at Mint, where he heads the personal finance
team. Neil is a graduate of law and economics. He also has a postgraduate
diploma in investments from the University of Birmingham, UK, and has
passed the CFA Level 1 exam. He started writing about personal finance in
2016 at Value Research, a mutual fund research portal. After a few stints at
fintechs, Neil joined Mint in 2019 as a reporter covering mutual funds and
other investments. He was made an editor in 2021.
‘The best way to discover the Big Bull. A fast-paced narrative and nuggets
of interesting stories with deep dives into some of his picks make this a
must-read!’—Radhika Gupta, CEO, Edelweiss Mutual Fund
‘I like this book as it resists the temptation of merely amplifying the aura of
a revered personality and strives to offer balanced insights into the thoughts
and deeds of a man whose exploits are likely to be recounted for
generations to come’—Neil Parikh, CEO, PPFAS Mutual Fund
‘They don’t make investors like Rakesh any more. He was special. A “rare”
combination of chutzpah, skill and luck. This book shows you facets of
these qualities; especially how he bought Titan in the 1980s and nursed the
position for fifteen-plus years before it turned into gold. Or how he suffered
margin calls in 2002 and won like a champ after a knock-down. The book is
a must-read for the expert and the rookie investor alike. It was a privilege
knowing him for decades’—Shankar Sharma, veteran investor, and founder,
GQuant and First Global
‘The book nicely captures the real person behind the persona. While Rakesh
Jhunjhunwala’s wins are well-documented and celebrated everywhere, it’s
interesting to know he also made mistakes and rapidly learnt from them to
make himself a better investor and trader. At heart, he remained a student of
the market for life’—Vijay Chandok, MD and CEO, ICICI Securities
NEIL BORATE, APRAJITA SHARMA & ADITYA
KONDAWAR
Foreword
Introduction
Rakesh Jhunjhunwala’s Timeline
Dalal Street is a lane in the Fort area of Mumbai where the erstwhile
Bombay Stock Exchange (now BSE Ltd) is located, in Phiroze Jeejeebhoy
Towers, a twenty-nine-storey skyscraper.
Of course, with the advent of technology, the physical location of a stock
exchange does not really matter much any more, given that the buying and
selling of stocks happens online and not in the trading ring of what used to
be the Bombay Stock Exchange. Nonetheless, the term ‘Dalal Street’ is
really the metonym for the Indian stock market. This despite the fact that
the National Stock Exchange, the bigger of the two exchanges, is located at
the Bandra Kurla Complex (BKC) in Mumbai.
Other than the buying and selling of stocks, something that is intricately
linked to the idea of Mumbai is the Hindi film industry. Much of the Hindi
film industry is based in and around the western suburbs of Mumbai, quite
some distance from Dalal Street. And it’s perhaps somewhere in these
western suburbs that the writers Saurabh Shukla and Anurag Kashyap
penned the rather memorable line, ‘Mumbai ka king kaun?’, for the film
Satya.
In the fictional world of Satya, the gangster Bhiku Mhatre wanted to be
king. But in the real world of buying and selling stocks, Rakesh
Jhunjhunwala was the king. And unlike the fictional Mhatre, he didn’t need
to mouth any dialogues to tell the world that he was the king—the Big Bull
of Dalal Street. Whenever he did speak, as he often chose to do, investors
latched on to every word that he had to say.
But despite the status that Jhunjhunwala had in the Indian stock market
and in the minds of Indian investors, there have been next to no attempts
made to study him and his investing style in some detail.
In comparison, there are so many books available on the star American
investor Warren Buffett. In fact, a lot has been written about other big
investors, such as George Soros, Jim Rogers, Peter Lynch, Charlie Munger
(Buffett’s investing partner), Bill Ackman, etc.
But if you were to log on to Amazon India right now and search for a
book on Jhunjhunwala, you are bound to be disappointed in not finding
anything good enough to read. Hence, this attempt by Neil, Aprajita and
Aditya is indeed very admirable. It’s a big first and a good first.
The book does a thorough job of first establishing the human behind the
mind and then giving the readers chapters on the stocks that Jhunjhunwala
made big money on, including Titan and CRISIL. It also elaborates on his
investments, such as DHFL, which went wrong. In that sense, the authors
try to maintain a sense of balance and don’t fall for the quintessential
mistake made by Indian investors and stock market gurus of being bullish
all the time.
Also, it needs to be said here that in a world thriving with attention
deficiency, the authors do a good job of keeping the chapters short and
simple, without making things simplistic.
My favourite chapter in the book is the last one, where the authors tell us
what not to learn from Jhunjhunwala. All geniuses have their quirks as well
as their weaknesses. In Jhunjhunwala’s case, a quirk was his love for
leveraged trading, something that not every ordinary mind is built to handle.
On the weakness front, Jhunjhunwala loved to drink and did so rather
unabashedly. As a Delhi-based stockbroker friend of his puts it in the book:
‘He often tried quitting drinking, to the extent that he would admit himself
to the hospital, where one cannot drink. But all his efforts were in vain. He
would go back to his old habits in just ten to fifteen days.’ Further, as the
authors point out, ‘The passion and discipline he exercised in the
investment world were almost completely absent when it came to his
health.’ And it’s this lack of discipline that ultimately led to Jhunjhunwala
dying young in August 2022.
To conclude, the authors have rightly focused the book on
Jhunjhunwala’s investing style and what one can learn from it. Nonetheless,
one factor I wish the authors had explored in detail was Jhunjhunwala’s
habit of equating the success of investing in Indian stocks with the health of
the Indian economy, which are two reasonably different things.
One can understand that Jhunjhunwala’s interest was in driving up the
value of his investment portfolio and to ensure that, he said what he did.
But this is not a distinction that the average retail investor, who held on to
every word Jhunjhunwala said, has the ability to make.
All in all, this is a great book for every reader who wants to understand
why Rakesh Jhunjhunwala was such a success at doing what he did, in the
time that he spent in this world.
11 February 2023
Prabhadevi
Mumbai
Vivek Kaul
author of the
Easy Money trilogy and columnist at Mint
Introduction
Neil Borate
Aprajita Sharma
Aditya Kondawar
Rakesh Jhunjhunwala’s Timeline
In this part, we give you a glimpse into Rakesh’s early life and how he
entered the stock market. We cover his initial days on Dalal Street when he
was one among many and how he rose to the top to become the one and
only. We introduce to you Rakesh Jhunjhunwala as a family man and as a
friend.
Chapter 1
A Chubby Boy
One of the greatest stock-market investors who has ever lived, Rakesh
Jhunjhunwala never managed a penny for someone else. Investors the world
over would have gladly given him billions for fund management, but the
man chose to build his empire through his own money. ‘I don’t want to be
answerable to anyone,’ he would often say in interviews. He loved his
freedom. ‘My wife is my only client,’ he would say.
To be sure, although Rakesh may not have entered the asset management
business, he did borrow money from individuals in his initial days at high
rates—promising them even higher returns than fixed deposits. The self-
made billionaire earned his fortunes with his own talent. ‘My brother was a
practising chartered accountant. He managed to get me a loan of about Rs
20 lakh from his clients. That is how it all started. I earned Rs 25 lakh in the
first year of my life in the stock market in 1985–86,’ he said.
There is an anecdote that Rakesh began with a capital of Rs 5000. That
was, most likely, the amount in his bank account that he had earned during
his CA articleship. However, it was the loan of Rs 15–20 lakh from his
brother’s clients that really allowed him to make his initial returns at scale.
Rakesh would elaborate on these early loans in media interviews after he
had built much of his fortune. In an interview with investment guru Ramesh
Damani, recorded on CNBC in 2011 (Wizards of Dalal Street), Rakesh said,
‘There was a lady. At that time, FD interest was 10 per cent. I offered
investors a return of 18 per cent. I had no security, but I told her after fifteen
days I’ll give security,’ he said, referring to the shares he had bought.
Another loan he recounted was from ‘a Christian gentleman, Mr Mendonza,
who gave a Rs 5 lakh loan’. It seems that Mr Mendonza didn’t even ask
Rakesh for security against the loan and Rakesh paid him an interest rate of
24 per cent. Rakesh used the money he borrowed from these early loans to
invest in the stock market. This is a highly risky practice and a few wrong
bets could have easily ended the budding stock market investor’s career.
This was the pre-Internet era, when stock-market information was often
passed by word of mouth and physically being near the exchange helped. ‘I
would stand there and talk to people. I never told anyone that my father
worked for the Income Tax Department, or they wouldn’t talk to me. I used
to tell them that he had a clothes shop,’ Rakesh later recounted.
Interestingly, Shankar Sharma, an investment guru whose career largely
coincided with Rakesh’s, says that physical presence in the trading ring
conferred no real informational advantage. ‘I was also a floor trader, we
were all active on the floor of the exchange. I don’t think it was any
advantage. I mean, that was just the method of trading. The real advantage
came from knowledge of trading itself, which I think is very important
knowledge. Whether you traded physically on the floor or in front of a
screen, what’s different is only the method of trading,’ he said. Despite
Sharma’s opinion, the physical nature of trading in the late 1980s and early
1990s did allow brokers to get away with high commissions and in some
cases, malpractice.
In the mid-1980s, the Indian economy was still highly controlled, with
the Licence Raj in effect. A few reforms were underway in sectors such as
telephony, but there was no significant wealth creation. The Bombay Stock
Exchange (BSE) was the country’s largest stock exchange and had a nearly
100-year history. Trading was done manually on the exchange floor and
some malpractices were rampant among stockbrokers. Orders were
sometimes not honoured and commissions were high, at 3–4 per cent.
Clients had to place their orders over the phone and often learnt the price
the next day. The opacity of the system allowed brokers to short-change
clients by charging higher prices than the actual trade or by declining trades
on grounds such as ‘signature mismatch’. The BSE Sensex was launched in
1986 with 1977–78 as the base year and a base value of Rs 100. It was in
this environment that Rakesh began his investing career.
Rakesh’s first stock was Tata Tea in 1986. He bought 5000 shares of Tata
Tea at Rs 43 and the stock rose to Rs 143 within three months, multiplying
his money three times over. Another one of his early buys was Tata Power.
According to Rakesh, there was a dip in the market after 1986 and he
bought 5000 shares of Tata Power, only to watch it recover handsomely. ‘At
that time, power companies were getting a fixed return as per the Electricity
Act. There was some talk of linking it to capacity utilization (the amount of
power generated by the company). Tata Power’s capacity utilization was
100 per cent. Tata Power would have benefited. I bought it at a price of 150
rupees. There was a dividend of 18 rupees,’ he recounted in later interviews.
Ramesh Damani, an investor who remained a close friend of Rakesh’ s over
many decades, met him around this time. ‘I was extremely fortunate that I
had come back from America to start my business. Suppose, on the reverse,
you’re going to America. And the first week of going to America, you meet
Warren Buffett, Charlie Munger, Peter Lynch. It gives you a distorted sense
of reality. But that’s exactly what happened to me. When I came, I met R.K.
Damani, who introduced me to Rakesh Jhunjhunwala. This must have been
1988. It is right at the start of my career,’ he said.
In 1986, in his first year in the stock market, Rakesh earned Rs 25 lakh
from his stock trading. For the next three to four years, there was no
earning. ‘They were bear years. I used to go to the ring, but I never
speculated,’ he later recounted in a conversation with Ramesh Damani.
‘The market was bearish. But I was staying with my parents. My wife
had a car but we used to go by bus,’ he said. Rakesh kept most of his
portfolio in Tata Power in this period and earned dividends from this
investment, he said in a lecture at FLAME University, Pune in 2013. ‘It had
a 30 per cent dividend yield,’ he added. Dividend yield is the dividend paid
by a stock divided by its stock price. The higher the yield, the greater the
return in terms of regular income that your investment makes. Ordinarily,
an index like the NIFTY or Sensex will have a dividend yield of 1–3 per
cent, making a yield such as 30 per cent truly exceptional. Apart from the
advantage of living rent-free in the parental home, Rakesh was also
financially supported by his family. ‘My wife came from a good family. She
had her own car. But we used to contribute no money to the household. If
my family had not supported me, I would’ve had to leave the market,’ he
said in the lecture.
However, his father never gave him a penny to invest in the stock market.
During the dry years after his initial success, he eventually went to his
father to ask for capital. All he needed was Rs 12 lakh to set up his office. ‘I
told him I would return the money in the next three years. I felt it was my
right to get the money because I had already proven that I can earn profits
in the stock market. All I needed was capital,’ he said, sharing the story at
his special address to young children at the Young Indians Youth Conclave
in Mumbai in 2014. He said his father refused to give him money quite
sternly. ‘You have a right only in your ancestral capital. I am afraid your
grandfather didn’t leave any,’ Rakesh quoted his father as saying.
Chapter 3
Investment Musings
The journey of a thousand miles begins with a single step, and the journey
of Titan began with one watch. Today, every three seconds, someone
somewhere around the world buys a Titan watch. Titan started in 1984 with
just one product category—watches. Xerxes Desai, a senior executive with
the company, was looking for new business opportunities for the firm when
he chanced upon the idea of watch manufacturing in 1977. The Titan story
is documented in detail in the book Titan: Inside India’s Most Successful
Consumer Brand by Vinay Kamath, published in 2018, parts of which we
will rely upon, along with Titan annual reports, in this chapter.
After almost a decade of tenaciously navigating through the public-sector
Hindustan Machine Tools’ (HMT) hegemony, the reluctance of the Swiss to
part with watchmaking technology, the Licence Raj and RBI’s stringent
forex norms, Titan was formed as a joint venture between the Tamil Nadu
Industrial Development Corporation (TIDCO) and the Tatas in 1984.
TIDCO had been looking at a few projects and its talks with other
watchmakers hadn’t borne fruit. To provide much needed foreign exchange
to finance the purchase of the required capital equipment, assistance was
sought from the International Finance Corporation (IFC), based in
Washington DC. The IFC is the private sector-focused sister entity of the
World Bank. The IFC was so enamoured by the project, it even sought to
make an equity investment in Titan.
Titan chose to locate its first plant in Hosur and its headquarters in
Bangalore. The fact that HMT’s watch plant was located in that city was a
major incentive. Xerxes said as much in an interview published in
Businessworld magazine in December 1989. The main reason for choosing
Hosur was its proximity to Bangalore. They thought it would be easier for
them to pull people out of HMT especially the ones with technical and
managerial experience. They wanted to raid HMT and they were successful
with the same. It was a blessing in disguise for them as HMT was
overflowing with staff and the growth avenues at the top-level management
weren’t many, which made the raiding even easier.1
Titan launched with five watch collections: Exacta (steel), Fastrack
(sporty models for the youth), Classique (gold-plated dials with leather
straps), Spectra (two-tone—steel and gold) and Royale (gold-plated dials
with gold-plated metal bracelets). The lowest priced was Fastrack, at Rs
350, and the highest was Royale at Rs 700. From day one, Titan was
projected as a premium brand. That first day at the Safina Plaza showroom,
Titan sold seventeen watches; the first month’s sale was 313 watches. The
Classique range was the bestseller, accounting for 65 per cent of sales.
However, the journey was not without its hiccups. From the initial batch
of Titan watches manufactured in December 1986, J.R.D. Tata was gifted a
watch. To the embarrassment of the Titan team, the quartz watch given to
Mr Tata was not working. In the 1990s, Titan took the disastrous decision of
entering the European market. Used to working in a monopolistic
environment in India, Titan was unable to match up to the exacting
standards of delivery and quality that watch retailing in Europe involved. It
was a struggle, recalls Ajoy Chawla, a young manager in the early 1990s
who would later head new business incubation and strategy for Titan
Company Ltd, even to pay salaries and the rent for the premises. The effect
was very clear on the financials—despite growing revenue from Rs 700
crore in 2000–01 to Rs 800 crore in 2002–03, net profit decreased from Rs
23.5 crore in 2000–01 to just Rs 11.5 crore in 2002–03. Titan was going
through a tough phase. It was a trying time for Bhaskar Bhat, who took over
as managing director in 2002.
The management was asked to come up with a winding-up plan and
bring back the stock and whatever cash remained. It was a difficult period:
the audit committee had TIDCO representatives and there was a great deal
of mistrust and suspicion. Finally, in 2004, a couple of years after Xerxes
Desai had retired, the European operations were brought to a stop. The
accumulated losses added up to Rs 182 crore and it took several years for
Titan to wipe it off the balance sheet. While Indian operations continued to
be profitable—Titan made Rs 21 crore in net profit in 2004–05 and Rs 99.9
crore in 2006–07—the overhang of the European losses troubled the
company for a long time. Xerxes Desai had seen success in the Indian
market, while the European foray was a failure. However, a catalyst for
Titan’s turnaround was the entry of Bhaskar Bhat as its MD on 1 April
2002.
When Bhat took over the reins at Titan, the company’s market value was
a mere Rs 220 crore, a tenth of Tata Power’s and around one-fifteenth of
Tata Steel’s and Tata Motors’. Now, Titan is valued at Rs 2,18,000 crore. It
is the second-largest Tata company in terms of market capitalization, after
Tata Consultancy Services. Moreover, between 2001–02 and 2018–19,
Titan’s revenues and profits grew at an annual rate of over 20 per cent and
30 per cent, respectively.2
It is unclear exactly when Rakesh Jhunjhunwala first entered Titan. But it
is confirmed from a video interview that he made a significant purchase
around this time, in 2001–02, at a price of Rs 30–32 per share.
The Big Bull in an interview said, ‘I didn’t know zilch about Titan. One
day I was sitting, I was very bullish, a broker called Daaki called me. He
said five lakh shares of Titan, which were trading at Rs 34, were available
to him at Rs 32. I called my friend Lashit, he said not to buy it as Morgan
Stanley was expected to sell 90 lakh shares and that I will get it cheaper.
But I didn’t listen to him and bought those 5 lakh shares and slowly
accumulated 12.5 lakh shares. I thought not to leave the shares despite
Lashit’s view. When the stock reached Rs 43–44, I went to meet the
managing director of Titan, Bhaskar Bhat. I had gone to many Tata offices,
but this one was totally different. All young people, vibrant office space,
etc. I had a meeting at 6 p.m. Bhaskar Bhat was so respectful, disciplined
and dedicated that he came at 6 p.m., but due to some union meeting, he
said he will be late by thirty minutes. He gave me a conference room to sit
in. He came at 6.45 p.m. and the meeting lasted for four hours till 10.45
p.m., where I was explained everything about the company and the
approach. He told me honestly that the task is difficult but they will do it.
Bhaskar’s wife called six times and finally he told the secretary to pass the
phone to him.’
‘I look at the sheer size of the opportunity and I also tend to invest in
what the market tends to ignore. Because I think, in investment, that’s
where the greatest opportunities lie. I may be a momentum player as far as
trading goes, but where investments are concerned, I don’t believe in
momentum at all. Investments should be in those areas which the market
does not favour,’ Rakesh said in a Capital Ideas Online conference in the
year 2000.3
When asked how he built conviction on the Titan stock, he said that he
bought the stock at various stages at a price range of Rs 32–125. ‘You
cannot create a Titan company. When India booms and it will, their margins
will go up from 10 per cent to 14 per cent (FY20 margins were 10 per cent
and FY22 margins were 12 per cent for Titan). I have never seen a company
that has such integrity. Right now, it is a difficult period for them, but they
will re-create themselves. Even when the price from Rs 1600 in 2008 fell to
Rs 600 in 2009, that didn’t shake his confidence as he said India will grow
at double digits and the best is yet to come,’ he added in an interview with
ValueQuest.
He said he will live to see that day and then that day will be the time to
sell Titan.
How Bhaskar Bhat won the battle for India’s watch market
HMT was making analogue watches, but Titan launched with the more
advanced quartz technology. HMT was just a utilitarian product, enabling
customers to check the time, but Titan was positioned as a fashion
statement, targeting young India. They also focused on outlet locations
where there was high footfall; top management themselves scouted many
locations. It was also decided that Titan would deal directly with the
retailers since all existing distributors were beholden to HMT. Titan would
supply only against advance payment, a practice unprecedented at the time,
to ensure that retailers’ cash was tied up in Titan stock.
Advance payments would make for more congenial and efficient sales
visits because a salesperson would not have to start the call with the
unpleasant task of reminding the store owner about pending payments. In
spite of initial resistance, even internally, to the idea of ‘no credit to
dealers’, Titan put its foot down on that decision and insisted that that was
the only and the best way for Titan. This was an extremely unusual policy
stand and many from other industries were sure it would not work. But
work it did, and in spades; in fact, it was one of the biggest contributors to
Titan’s initial financial success.
The seeds of the franchisee model were also sown in these early sessions.
Titan proactively attracted businesspersons from outside the watch trade to
set up watch shops, even if they needed extra help to do it. Partly because
there were no middlemen, Titan could also offer retailers better margins. All
these policies served Titan well in the initial years; they were the key to
maintaining low working capital borrowings that enabled them to show
profits from the very first year of operations. Fast forward to today—Titan
today has sixteen brands, more than 2200 retail stores, having an area of 2.8
million square feet, and 7263 employees. Titan is the biggest wealth creator
from the Tata Group, having given almost 17,000 times the returns in the
last twenty years (at 2022 year-end price).4 Starting with watches, the
company successfully launched jewellery with Tanishq in 1995. It has since
expanded into eyewear—Titan EyePlus, accessories and fragrance (Skinn),
and its latest venture of sarees by the name of Taneira. However, among
these brands, the most important to Titan’s success story is Tanishq.
Tanishq
The birth of the Tanishq brand is a very interesting story. The P.V.
Narasimha Rao-led government said that companies such as Titan would
need to generate their own foreign exchange to fund their imports. Titan
was told that the Government of India had no foreign currency to give. So
they started looking for a project that could allow them to sell products
overseas. In the mid-1990s, Xerxes Desai hit upon the idea of exporting
jewellery for the much-needed capex. This idea was formulated when Desai
visited an exhibition in Mumbai. Incidentally, the fair was called the World
Watch and Jewellery Show.
Desai, Titan’s first managing director, chose the name Tanishq. Tanishq
derives from Ta (from Tata) and nishq/nishk (in Sanskrit), which means
‘ornament’. However, this business also struggled for seven years. In the
1990s, Tanishq opened stores selling 18-carat jewellery, but Indians were
only interested in 22-carat jewellery. The stores made losses and the stock
price was left at just Rs 2. At the same time, the foray would turn out to be
more difficult than anticipated, as Titan found it difficult to sway Indians
from their family jewellers.
Titan’s 1996–97 annual report sheds more light on this phenomenon:5
While Tanishq jewellery has drawn praise and evoked a very favourable reaction among
consumers, the fact that our collection was initially confined to only 18 karat gold
jewellery, mostly gem-set proved to be a limiting factor in the attainment of volume
objectives. Work, therefore, commenced in right earnest on the creation of a new
collection of 22 karat gold jewellery based on traditional Indian design themes. Tanishq’s
22 karat collection has been launched recently and has evoked a most enthusiastic and,
indeed, very gratifying response. While the Company believes that an 18 karat gold alloy
is the most suited for jewellery—and is, in fact, the world standard for fine gold jewellery
—the existence of a very strong consumer preference in India for 22 karat gold jewellery
cannot be wished away. Our entry into this market segment will, it is hoped, accelerate
the trend towards an official hallmarking process which will significantly benefit the
consumer who, today, is often the recipient of substantially undercarataged jewellery
masquerading under the 22 karat label. In addition to the introduction of 22 karat ethnic
jewellery, the current financial year will see a significant increase in the number of
Tanishq showrooms as new outlets are opened in Calcutta, Ahmedabad, Hyderabad, Pune
and in several other towns. By the end of the financial year, Tanishq will have over 40
outlets in over 30 towns, representing India’s first jewellery store chain.
Thus, in 2002–03, Tanishq started selling 22-carat jewellery and also did
something very innovative that posed a very big threat to the competition.
They bought a lot of karat meter machines, which cost Rs 12 lakh each.
This was the first time in India where such machines could tell the purity of
jewellery in terms of karats—18 or 22—and whether the gold was pure or
impure. But this didn’t directly convert into business. When asked the
reason for this, customers replied angrily, ‘You are just telling us we have
impure gold, but not helping us.’
58 per cent of the jewellery that came for checking was less than 22-karat
purity, so Tanishq also launched ‘Impure to pure’. If the jewellery was
above 19 karats, Tanishq would exchange it for 22-karat jewellery and just
take making charges. This was revolutionary and it led to Tanishq finding
its value proposition of purity and trust with the customers.
The commendable thing about Tanishq was that it kept innovating.
Tanishq kept on launching new categories and sub-segments under
categories to keep the momentum going as it had realized that the Indian
market was unorganized, very large and underserved. In 2011, Titan
launched Mia, a stunning range of fine urban-chic affordable jewellery
crafted for working women. All the pieces in Mia were crafted in 14K gold
and the collection had over 500 designs. When growth slowed between
2013 and 2016, it innovated by reducing making charges, increasing new
launches backed by product innovation and offering gold exchange schemes
that nudged the consumers to up-trade. Tanishq has consistently
outperformed its peers.
CRISIL
CRISIL was India’s first credit rating agency. Fast forward to today, it is a
2.6-billion-dollar company that provides ratings, risk management systems,
valuation frameworks and advisory services. CRISIL was among the pillars
of Rakesh Jhunjhunwala’s portfolio. ‘One of the best stories about Rakesh
is that his mother once provoked him, “You are earning so well, can't
we live a bit better?” Rakesh sold some CRISIL shares and bought a large
apartment in South Mumbai. He would say later, “What I sold for less than
Rs 30 crore is now worth Rs 750 crore.”’1
In India, there are a total of seven credit rating agencies (CRAs) that are
allowed to give ratings to companies on the level of risk in their bonds. The
ratings market is dominated by three of them, (i) CRISIL (ii) ICRA and (iii)
CARE, which together cover around 95 per cent of the industry. CRISIL is
the market leader. CRISIL employs more than 4000 professionals. It has
offices and research centres in eleven countries including the US, the UK,
Singapore, Japan and Australia. CRISIL has 3396 professionals working
across their India offices with the rest abroad as per their FY21 annual
report. (The FY22 annual report was yet to be published as of the date of
writing this book.)
CRISIL is majority-owned by S&P Global Inc., the world’s foremost
provider of credit ratings, benchmarks and analytics in the global capital
and commodity markets. CRISIL’s clients range from micro, small and
medium enterprises (MSMEs) to large corporates, investors and top global
financial institutions. CRISIL works with commercial and investment
banks, insurance companies, private equity players and asset management
companies globally. They also work with governments and policymakers in
the infrastructure space in India and other emerging markets.
CRISIL has seven broad-based product categories: ratings, SME
solutions, Indian research, global research and risk solutions, global
analytics, infra advisory, business intelligence and risk solutions.
CRISIL was created in January 1987. It was jointly promoted by the
Housing Development Finance Corporation (HDFC), Industrial Credit and
Investment Corporation of India (the erstwhile ICICI Ltd) and a few other
financial institutions. There was an industry need for a business that would
aid the development of a bond market in India and this was why Narayanan
Vaghul and Pradip Shah, bankers from ICICI and HDFC respectively,
created this institution, CRISIL, that created and pioneered an entire
industry around ratings in the late 1980s and early 1990s.2
When CRISIL started, the concept of credit ratings was way ahead of its
time. India had no such thing as a corporate bond market, its business
environment wasn’t really positive and lending rates were fixed. CRISIL’s
first client was Indian Petrochemical Corporation Limited (IPCL), which
was a Rs 625 crore public-sector unit and was India’s largest vertically
integrated petrochemicals manufacturer.
Within two years of commencing operations, CRISIL established a who’s
who of a client list. It included Ashok Leyland, the Birla Group,
Cholamandalam Investment and a few more well-known business names.
Having an independent rating process that was influenced by CRISIL’s
principles and not the client’s principles or vested interests had its own set
of problems, however. Some clients were unhappy, some went away and
some rejected their ratings. Some even tried their sources in the RBI,
government institutions and other powerful institutions to try to get CRISIL
to give ratings in their favour. If this was not enough, one client even
threatened to destroy them. However, Mr Shah decided not to give in at any
cost.
The period from 1990 to 2000 was a momentous time for CRISIL. It
started off in 1990 by providing comprehensive information and analytical
opinion on India’s corporate entities via its ‘CRISIL card service’. In 1992,
thanks to CRISIL’s training and technical assistance, Malaysia Berhad, a
rating agency, and Maalot, the Israeli securities rating company, came into
being. One very important milestone was in November 1993, when CRISIL
came out with its IPO. It was a great success—its 20,00,000 shares, sold at
a premium of Rs 40 per share, were oversubscribed by 2.47 times. In
December 1995, it made its stock market business foray by developing and
launching the CRISIL500 Equity Index. The seeds of one of the defining
partnerships in credit ratings were sown in February 1996 when CRISIL
forged a strategic business alliance with Standard and Poor’s (S&P) Ratings
Group. This was further strengthened when S&P acquired a 9.68 per cent
stake in CRISIL in May 1997. CRISIL always wanted to get into non-rating
businesses so that they were insulated from downcycles in the rating
business. In 1996, CRISIL got into advisory services as well and got their
first major order win in the infrastructure policy advisory domain. CRISIL
also set up India Index Services Limited (IISL), a joint venture with the
National Stock Exchange of India Limited (NSEIL), to provide indices and
index-related services in Indian capital markets.
From educating companies about their products and the need for credit
ratings to the CRISIL frameworks actually becoming industry-standard, life
came full circle for CRISIL in 1999 when their proprietary Risk Assessment
Model (RAM) became the banking industry standard.
R. Ravimohan had started his career with ICICI, where he worked on
project appraisals and merchant banking, besides a host of other things. In
1994, when Pradeep Shah moved to Indocean, R. Ravimohan was elevated
to MD.
In the space of the ten years that he was CEO, R. Ravimohan batted for
diversification beyond the ratings businesses. He oversaw three big
acquisitions, helping CRISIL transform into a ratings, research and
analytics company. During his tenure of thirteen years with CRISIL, he also
helped create a crucial and strategic partnership with S&P, a leading
international ratings firm, that eventually led to S&P acquiring a majority
stake in CRISIL in 2005, a recognition of the significance of the Indian
firm.
Interestingly, Ravimohan moved to S&P in 2007 and Roopa Kudva, a
fifteen-year veteran at CRISIL who had joined in 1992 as a senior rating
analyst, took over as the MD and CEO. Kudva helped the company scale up
in the global arena through acquisitions in the global research and analytics
business and expanded the ratings business in India by rating small and
medium-sized enterprises (SMEs). CRISIL’s core businesses today are
ratings, global research and analytics (GR&A), India research, capital
markets research and infrastructure advisory and risk solutions.
Between 2000 and 2010, CRISIL made four major acquisitions that
helped them achieve explosive growth and fit right into their vision of
widening their business spectrum. This decade was all about acquisitions,
agility and expanding product spectrum. There was one event that changed
the trajectory of this company. This was not without some failures, though.
CRISIL’s first acquisition was INFAC in 2000. The acquisition was to get
into industry research and outlook, something CRISIL did not have in its
bouquet of products. The INFAC acquisition helped CRISIL hit two targets
at once—eliminating competition and bringing in much-desired research
capabilities.
CRISIL made a flawed decision and had to contend with the
consequences when it launched the Healthcare Institutions Grading product
in 2002. This was the culmination of a year’s painstaking research and
collaboration with a leading hospital chain in the country. Ravimohan, the
then CRISIL chief, embarked on a mission to bring this product to life after
protracted discussions with Apollo Hospitals. The product was closed in
2007, twenty grades and five years later. The learning? Not to get into areas
where they had no expertise.
CRISIL’s first overseas acquisition was EconoMatters Ltd in 2003 (later
the Gas Strategies Group), a London-based company providing natural gas-
related consulting, information and training, and conference-organizing
services. This wasn’t their last overseas acquisition but one that would teach
them a lot in the years to come. CRISIL had a lot of dependence on the
acquired company to show synergies. To make things worse, the
management team of Econo had no connect with the CRISIL team and
organization. It never fit in. CRISIL divested 90 per cent of the investment
in 2008 and had exited completely by 2010.
On 26 April 2005, S&P completed its acquisition of a 51 per cent stake in
CRISIL. Rakesh Jhunjhunwala also tendered his shares in the open offer
(when company A acquires a significant stake in company B, it is required
to provide an opportunity to the existing shareholders of company B to sell
their shares. This is referred to as an open offer. In India, an open offer is
triggered when the acquirer buys a 25 per cent or higher stake. The
acquiring company is required to make an open offer for at least 26 per cent
additional shares, at a price not below the average price of the past twenty-
six weeks. This provides minority shareholders an exit route in the event of
a new management taking over). In a statement from New York, S&P
president Kathleen A. Corbet said, ‘A majority position will enable S&P to
integrate CRISIL more fully into our operations for the benefit of the Indian
and international marketplace.’ It had been a fruitful journey between both
the premier institutions till now, which was about to get even more eventful.
However, despite being acquired, CRISIL continued on its growth path
and its own acquisition spree. Irevna, which was into equity research, was
their second overseas acquisition in 2005 (third in the year, fourth overall).
It was a leading global equity research and analytics company. Until this
acquisition, CRISIL only thought about the Indian market, but this
acquisition helped them step up their game and develop a global mindset.
Pipal Research, CRISIL’s most recent acquisition in 2010, was a
continuation of this ethos. This was to gain a foothold in the corporate
business and investment research services market. This acquisition also
complemented the Irevna portfolio as these two combined led to a unique
product and geographical positioning: high-end analytical offshoring with
the widest range of services, with leadership in the high-end global research
and analytics space.
With the CRISIL engine moving forward, growing geographies and
expanding business lines, its story was received well by all investors, who
were happy with the company delivering good growth and being proactive.
By 2011, ratings as a business was contributing only 40 per cent to
CRISIL’s top line, a huge change since ratings were the bread and butter for
the group and the flagship business. CRISIL had come a long way and they
had been successful in widening the scope of the firm’s services. They were
a truly diversified firm. The Irevna acquisition was a huge success, having
grown manifold under the CRISIL brand. ‘Rakesh started buying CRISIL
shares in 2003. After buying 10,000 shares initially at Rs 150, he later
increased his holding to 5.5 million shares as of September 2006. He
accumulated the CRISIL stock between Rs 400 and Rs 500. In 2013, Rekha
Jhunjhunwala offloaded 4,00,000 shares for over Rs 46 crore.’3 Currently,
Rekha Jhunjhunwala and her late spouse, Rakesh, own a 5.47 per cent stake
in the ratings agency, which is worth Rs 1200 crore (September 2022
shareholding data and 26 October 2022 price taken for calculation). One of
the best stories about Rakesh Jhunjhunwala is that his mother once taunted
him about being miserly. ‘You are earning so well, can’t we live a bit
better?’ she said. Rakesh sold some CRISIL shares in 2004–05 and bought a
large apartment in South Mumbai. The CRISIL stock continued to rise.
Although it is unclear exactly when in 2004–05 he sold CRISIL stock (the
CRISIL stock price tripled in that year alone), by 2022, it had risen about
eighteen times from its price at the end of 2005. What he sold for less than
Rs 30 crore was worth Rs 1300–1500 crore at the 52-week-high price of Rs
3863.55 (that was observed on 3 May 2022) of the CRISIL stock (rough
estimates).
Chapter 8
Lupin
‘There is only one reason why we exist—to treat diseases, to heal and enrich human life.’
—Late Desh Bandhu Gupta
Company’s phases
In 1979, the company established the first formulations facility and research
and development centre in Aurangabad, India. In 1987, Lupin’s cephalexin
facility in Mandideep (Madhya Pradesh) and its Ankleshwar plant went
online. Afterwards, Lupin began producing anti-TB pharmaceuticals, which
at one point accounted for 36 per cent of the company’s revenues and made
it the largest producer of TB medications in the world.4 For a long time,
Lupin mainly had one anti-TB drug, Rifampicin, a low-margin product with
government controls. Lupin started out as an API player for the anti-
tuberculosis segment before getting into formulations.
According to an MIT Sloan School case study (titled ‘Biocon India
Group’, written by Archana Kalegaonkar, Richard Locke and Jonathan
Lehrich dated 4 November 2008), ‘starting in its earliest days, the pharma
industry in India experienced phenomenal growth. A combined bulk drug
and formulations output of Rs 168 crore in 1965 grew to Rs 19,737 crore
thirty-five years later—an annual growth rate of 15 per cent. Roughly two-
thirds of the output stayed in the domestic market which, by the year 2001,
was also growing at 15 per cent annually. The remaining one-third3—Rs
6631 crore—went to the export market, which had a 21 per cent growth
rate. By the beginning of the twenty-first century, over 20,000
pharmaceutical companies were operating in India.’
It all started with the 1972 Patent Act, when ‘product patents’ were
disregarded. In 1970, MNCs dominated the market. The 1972 Patent Act
allowed ‘reverse engineering’ that enabled Indian companies to reverse
engineer drugs and take market share. Formulation sales in India rose from
Rs 150 crore in 1965 to Rs 7935 crore in 1995. API exports started in the
1970s but really acquired pace after 1996. Bulk drugs production
accelerated from Rs 18 crore in 1966 to Rs 1518 crore in 1995. India also
began exporting pharmaceutical formulations to developing markets. The
share of exports in total production increased from 3 per cent in 1980–81 to
24 per cent in 1994–95, with 90 per cent of exports going to developing
markets.
An unrelated diversification into real estate didn’t work and Lupin was
saddled with bad debt (details about this are not available). ‘Worse still, the
stock was associated with the manipulations of tainted stockbroker Ketan
Parekh. As investors clamoured for change, DBG decided to professionalize
the company pretty early on and brought on board Kamal Sharma as the
MD in 2003, with a mandate to reinvent and take on peers Ranbaxy and Dr
Reddy’s, who were expanding to new markets like the US.’3
In 2001, Lupin was just a Rs 280 crore market cap company with sales of
Rs 900 crore. The real trigger came when governance improved. This
improvement was led by Dr Kamal K. Sharma and his leadership team.
He was the one who oversaw the rise of Lupin from Rs 1120 crore
business to Rs 13,702 crore (reported in fiscal 2016), with 72 per cent in
revenues from its international operations in seventy-six countries.4 He
joined when the stock price of Lupin was Rs 50. At the end of FY16, the
stock price was around Rs 1500.
Sharma helped Lupin diversify from being a company best known as one
of the largest manufacturers of anti-TB drugs into a range of affordable
generic and branded formulations in many markets. Lupin has also acquired
several pharma firms across the world and Sharma has made it the first
Indian company to successfully market an individual branded drug, Suprax,
in the US. Former colleagues of Sharma used to say he was an expert at
understanding the pharma sector. ‘He used this to pull off a coup in a
licensing deal while at RPG. Sharma beat a licensor down to $500,000 from
$7 million it had sought.’5
They also moved up the value chain and mastered the business of certain
intermediates and APIs. They leveraged their strengths to build a
formidable formulations business. It has a significant presence in
cephalosporins, cardiovasculars (prils and statins), diabetology, asthma and
the non-steroidal anti-inflammatory drugs (NSAIDs) therapy segments.6
At the start of the new century, Lupin made some bold moves, which accelerated revenue
growth and propelled the company into a different orbit over the next ten years: (a) entry
into the US market—transition from low-cost to branded generics in the US when no
other Indian manufacturer had been able to establish a meaningful presence in the
category; (b) change in the India business strategy—a focus shift from acute to chronic
therapies and formulations for APIs; (c) entry into Japan—Lupin became the first
international generics company to gain a foothold in Japan. The above efforts resulted in
23 per cent revenue CAGR from FY04 to FY17.7
Lupin grew faster than the industry at 20 per cent CAGR from FY01 to
FY17. The industry grew at 17 per cent during these fifteen years.
In 2015, the Lupin share price had reached almost Rs 2000 at its peak, but
then many US FDA issues cropped up, not just for Lupin but for many
Indian listed pharma players. In 2015–16, pharma companies’ Indian
facilities were issued twenty warning letters as per Lupin’s September 2017
presentation. Data integrity was the biggest cause of the warning letters in
these two years. But there were also other compliance issues—procedures
not being followed, scientifically unsound laboratory controls and
investigation of discrepancies and failures. This cast a very big shadow on
the compliance levels of Indian pharma companies as critical functions
were not being followed properly.
‘Around 2015–16, Lupin started facing increased problems in its US
business due to increased generic competition, generic price erosion and
customer consolidation. This was accentuated by a spate of US FDA
observations, impacting the company’s financial performance in the last
few years.’8 US generics revenue became subdued from FY15 onwards.
Operating profit/EBITDA margins also reduced with the decline in US
revenue after FY15.
Due to the business environment worsening, the company’s return
efficiency ratios also started falling. The return on capital employed, which
is used to assess a company’s profitability and capital efficiency, declined
for Lupin and the industry as a whole. This ratio helps us understand how
well a company is generating profits from its capital. The working capital
cycle was also stretched. The Working Capital Cycle (WCC) is the time it
takes to convert raw material into actual revenue inflows. A long cycle (a
greater number of days) means more time taken to earn revenue and a
greater number of the days the raw material is being stuck in a process.
Short cycles (a smaller number of days) mean quicker conversion into
revenue that allows a business free cash to redeploy it again for other
purposes, which leads to agility. The WCC for Lupin was
elongated/stretched as receivables (money they were supposed to receive)
surged after consolidation in the US market. There was also a continuous
build-up of inventories (meaning raw material was stuck on the company’s
balance sheet) in US subsidiaries.
In July 2015, the company announced its intention to acquire Gavis
Pharmaceuticals and Novel Laboratories for $880 million. When it comes
to US FDA compliances, Lupin went from having one of the best track
records (till 2015–16) among its peers, to an average or subpar track record
as of today.
To put this in perspective, a few of their key plants got US FDA
observations one after the other. And not just that, there were repeat
observations at the Goa facility (in fact, there was a total of seven
observations during re-inspection, which showed a lax compliance
approach in the company given how they were inspected before also) in
September 2021. At present, five sites of Lupin either have warning letters
of Official Action Indicated (OAI) status from the US Food and Drug
Administration.
The company’s Goa plant was inspected in March 2017 and
subsequently, the company received a warning letter for the facility. The
plant was again re-inspected at the beginning of 2019, and the FDA had
then issued a ‘Form 483’ with two or more observations.9
In September 2017, the company, in its quarterly earnings release, talked
about how the current model of Indian pharma was ageing. In the US,
pricing pressure was visible and the space was becoming hyper-
competitive.10 In FY17, Lupin’s raw material cost, employee cost and other
expenses as a percentage of sales were 28.6 per cent, 16.3 per cent and 29.4
per cent, respectively. These costs added up to a total of 74.3 per cent of
sales, which in FY22 rose to a total of 86.8 per cent.11
Its gross margins (that show how well the company is managing its raw
material costs), at 67.4 per cent in FY15, fell to 60.5 per cent in FY22.
Return on equity (ROE) is a gauge of a corporation’s profitability and how
efficiently it generates those profits. The higher the ROE, the better a
company is at converting its equity financing into profits. For Lupin, the
ROE was 30.4 per cent in FY15, which fell to just 2 per cent in FY22—
again one of the highest falls in the industry. In March 2019, the US FDA
put several Lupin drug plants on notice for quality problems, and indicated
that it might not approve future Lupin drug applications.
In November 2019, Lupin made a provision of US$ 53.5 million (Rs 380
crore) to be paid towards the settlement amount in respect of a State of
Texas lawsuit in the US against Lupin for reporting inflated drug prices to
the Medicaid programme. If that wasn’t enough, Gavis, the very famous
acquisition, started showing cracks. Lupin made a lot of impairments after
the acquisition of Gavis, which dented many quarters’ net profits. The
company had to incur its first impairment on assets of Gavis Pharma in
January–March 2018, and the second impairment was in December 2019,
when it made a Rs 1580 crore impairment. ‘I would say that it (the write-
offs) is done, and what we have left on the books in terms of intangible
assets is $100 million, which is also supported by the business we have in
place,’12 chief executive officer Vinita Gupta said in a call with journalists
(the October–December 2019 quarter con-call). ‘Lupin posted a net loss of
Rs 511.9 crore for the fourth quarter of fiscal 2021–22 due to rising costs,
price erosion in the US and impairment expenses of Rs 126.7 crore for US-
based Gavis.’13
As we can tell from many of the events recounted above, this phase was a
very tumultuous one for Lupin, with bad capital allocations and a few
losses. Adjusted earnings per share growth rate for FY18–22 for Lupin was
-33 per cent. Operating to free cash flow conversion was just 11 per cent for
Lupin during FY13–22, which was the lowest among peers. This showed
that the company had very weak surplus generation capability. Now this is
important, as free cash flow helps the company fund future projects or R&D
projects or, say, buybacks with their own internal surplus and not rely on
external debt or equity raising, which can be very costly. In Q1FY23, it
reported its lowest quarterly EBITDA margin of 4.5 per cent due to
restructuring in the US as well as continuous inflation of raw materials and
freight.14 The US revenue stood at a multi-year low as well.
If we look at recent times, there are some early signs of course correction
but, more importantly, valuations are indeed compensating for past
mistakes. The company’s story has many moving blocks.
DHFL
All was going well, but the company started facing problems after FY17–
18.
Particulars/year (Rs
FY16–17 FY17–18 FY18–19 FY19–20
cr.)
Revenue 8857.2 10,464.5 12,902.5 9578.9
PAT (profit after tax) 2896.5 1172.1 -1036.1 -13,426.85
Deposits with DHFL 6769 9652 6588 5728.89
0.94 per 0.96 per 2.72 per 62.97 per
GNPA
cent cent cent cent
‘Only when the tide goes out do you discover who’s been swimming naked.’
—Warren Buffett
A2Z Infra
The background
Amit Mittal acquired the equity shares of A2Z Maintenance from its
existing shareholders between December 2003 and February 2004. The
company was initially engaged in the Facility Management System (FMS)
business and entered the Engineering, Procurement and Construction (EPC)
business in fiscal 2006. FMS can be defined as the tools and services that
support the functionality, safety and sustainability of buildings, grounds,
infrastructure and real estate. As an EPC player, with a special focus on the
distribution segment, A2Z had been providing services to the power
transmission and distribution sectors. EPC firms deliver a complete package
of resources to complete infrastructure projects. EPC services typically
provide a single responsible source for executing a project, thus alleviating
risk for the owner. The company was also into renewable energy, providing
municipal solid waste management services and even IT solutions to power
utilities.
A2Z carried out a lot of action on the merger and acquisition side to grow
themselves. To further strengthen their presence in the EPC business, the
company acquired Sri Eswara Sai Constructions Private Limited, a
company engaged in the installation of transmission lines, and merged it
into the company in January 2008.
To streamline operations and enhance their business focus, they
transferred their FMS business to their wholly-owned subsidiary, A2Z
Infraservices, in April 2008.
They increased their presence in the FMS segment in August 2009 via
the acquisition of Imatek, a company that initially held a 5 per cent equity
interest in CNCS (an FMS company). Imatek subsequently increased its
equity interest in CNCS to 51 per cent in October 2009.
In Q1 of fiscal year 2011, they entered into agreements to purchase
Surindar Chowdhury and Brothers, a partnership firm that was engaged in
the business of construction of electrical substations and railway
electrification work; Mohd Rashid Contractor, a partnership firm engaged
in the business of telecommunications and other EPC services; and En-Tech
Engineers and Contractors, a partnership firm engaged in the business of
telecommunications and other EPC services. They were also expected to
ramp up their holding to 51 per cent from 1 per cent in Star Transformers, a
partnership firm, engaged in the business of manufacturing and fabrication
of transformers.
The IPO
A2Z’s main business was installation of power distribution lines and
substations. The company, which started off with the not very glorious nor
unique business model of maintenance work, got its big business break with
the PSU Power Grid. Its big investment break came thanks to Rakesh
Jhunjhunwala. This became the company’s speciality, since he had picked
up 21 per cent stake in the company before they launched their IPO. He had
bought the stake in 2006 for around Rs 15 crore. With the company going
public, he planned to take some money off the table.
Even as the market was going nowhere, A2Z Maintenance decided to
come out with an IPO. The IPO was open from 8 to 10 December 2010.
The issue size was Rs 675 crore. In the run-up to the IPO, the company’s
financials were stellar. Revenue was Rs 181 crore in FY07, which rose to
Rs 1225 crore in FY10, an amazing CAGR of 89 per cent. Net profit was
Rs 11.1 crore in FY07, which rose to Rs 99 crore in FY10, an amazing
CAGR of 107 per cent. But during the same period, EBITDA margins had
not grown much, and margins were likely to be pressured going forward,
considering the growth plateau expected in the Indian EPC sector in the
coming years.1
Disregarding the advice of close friends, Rakesh pushed the management
to go ahead with the IPO in a weak market, and even leaned on some of his
friends and associates to ensure that the issue was fully subscribed.
‘Wear clothes that matter’ is a very famous quote when we talk about
dressing well. Perhaps Rakesh Jhunjhunwala took this policy a notch higher
and decided to invest in a company that made clothes that mattered. This
was Mandhana Retail Ventures.
Before we talk about Mandhana Retail Ventures, where the Big Bull
invested, we have to understand Mandhana Industries. This is because
Mandhana Retail Ventures had been demerged from this company. Rakesh
had invested in Mandhana Retail Ventures in 2016 after the demerger was
concluded. Besides Rakesh, it was the Salman Khan connection that would
keep the company in the limelight.
It was Mandhana Industries that originally had the rights to manufacture,
retail and distribute the brand products of Being Human, a brand that
Bollywood actor Salman Khan owns. Being Human operated as a retail
division of Mandhana Industries between 2012 and 2016. ‘The board of
directors of Mandhana Industries, on 22 November 2014, had approved the
demerger of the company’s retail and trading business under the brand
Being Human to Mandhana Retail Ventures Limited (MRVL). Shareholders
of Mandhana Industries received two equity shares of MRVL for every
three Mandhana Industries shares held. It was 14 December 2016 when the
demerger finally happened.’1
The sole rights of the brand Being Human went to MRVL post-demerger.
Being Human is a clothing brand that sells T-shirts, shirts and lowers for
men and tops and leggings for women. They also launched accessories
along the way, including caps, wallets and belts. Actor Salman Khan started
‘Being Human, The Salman Khan Foundation’. The foundation is
structured as a charitable trust to empower the underprivileged and
underserved through education and healthcare initiatives.
Mandhana Industries was incorporated as Mandhana Textile Mills Private
Limited, a textile trading company, on 25 July 1984 by Purushottam
Mandhana. Production and processing activities started in 1994. After
fabrics processing, they got into international garments by exporting to
European markets in 1998. Gradually, they expanded across cities in India,
from Delhi and Chennai to Bengaluru.
In 2010, the company launched an IPO to raise Rs 107.90 crore, where it
got Rs 15 crore from anchor investors. The company then established a
garment unit in 2013 in Tarapur with a capacity of 20,00,000 pieces
annually and another in Baramati with a capacity of producing 20,00,000
pieces annually.
January 2013 was when they inked an exclusive agreement with Being
Human. With this agreement, Mandhana got exclusive marketing, designing
and distribution rights for the brand for the next nine years and three
months. This was an important deal as Being Human played on three key
aspects that worked for its strong brand recall. The three attributes were that
1) the sales of Being Human went to charitable causes so the brand stood
for something larger than just clothes and people took pride in wearing the
brand, 2) designs and quality came at good prices, which worked very well
for a price-conscious market like India, and 3) the association and
branding/marketing by Salman Khan made it an aspirational brand for
viewers and fans.
In FY16, a year before the demerger, ‘Mandhana Industries Limited was
a multi-division, multi-geography company. It was one of India’s leading
textile and garment manufacturers. The company manufactured products at
its state-of-the-art facilities and exported to twenty-five countries. Vertical
integration enabled the company to span the entire textile value chain,
enhancing growth opportunities.’2
Over eleven years, from 2005 to 2016, the company’s financials had done
very well. From Rs 127 crore in FY05 and Rs 463 crore in FY09 to Rs 1646
crore in FY16, revenue grew at a CAGR of 26.23 per cent. Net profit had
increased from a mere Rs 6.4 crore in FY05 to Rs 37 crore in FY09 to Rs
57 crore in FY16, clocking a CAGR of 22 per cent. Exports had grown
from Rs 47 crore in FY05 to Rs 136 crore in FY09 to Rs 238 crore in FY16.
Debt-to-equity in 2016 had expanded to 1.5 times and this would come to
trouble them later, as we will see. In fact, in 2016, their net profit went
down to Rs 58 crore, from Rs 64 crore in 2015, due to an increase in
interest costs.3
Rakesh truly believed in the potential of India since the day he set foot in
the stock market. He had all the money in the world to go global, that is, to
look for investment opportunities beyond India. But forever an India bull,
he believed more in the Indian story than any global story. In fact, he was
averse to buying MNC stocks in his initial days. ‘He would get miffed at us
as to why we were buying MNC stocks. “Tum log MNC stock kyon kharidta
hai? Indian companies khatm ho gayi hai kya? (Why do you people buy
MNC stocks? Are there no Indian companies?)” he would tell us often,’
recalls one of his old friends.
In an interview, he himself mentioned that Radhakishan Damani and he
differed on many investment ideas, including MNCs. ‘R.K. Damani would
buy MNC stocks but I was averse to it. I don’t want to be a husband of an
unwilling wife. Let’s face it. The fact is, MNCs don’t want more
shareholders,’ Rakesh said in a 2015 lecture at FLAME University. Later,
he did invest in a few MNC stocks such as HUL, GlaxoSmithKline and
Nestlé.
His inherent optimism about India is what earned him the title ‘the Big
Bull of India’. You just have to recall a difficult phase in the stock market
and watch his interviews from those days. He had been a buyer in all of the
bear phases that the stock market has seen, be it the dotcom bubble burst of
2000, the global financial crisis of 2008, the recent Covid-19 crash in
March 2020 or the Russia–Ukraine war in 2022. ‘In 2000, the dotcom bust
had hurt Jhunjhunwala and Damani in a big way. Damani had had enough.
He went on to launch the one-stop supermarket chain D-Mart while
Jhunjhunwala invested back in the stock market whatever he was left with.
Hardly any investor dared to take positions in the market during those days
but he believed in India’s growth story and potential in the stock market,’
recalls his old friend.
His optimism paid him well. His wealth multiplied by many times during
the bull market that had started after 2002. All the portfolio stocks that he
had bought in the 1990s, especially Titan, turned multi-baggers during this
phase. This is the phase that marked his shift from being a trader to a smart
investor. ‘In 2001–02, I realized India is on the threshold of a secular
growth story and wrote so in the Economic Times in June 2001,’ he said in
the FLAME lecture.
When the 2009 crisis hit the stock markets, Rakesh kept his nerve. ‘Now
is the time to buy the riskiest assets. Risk is a word with many dimensions.
But the way I see it—say I buy something for Rs 100. It could be that it
becomes Rs 60 or Rs 70 or Rs 40. But the way I envisage things—can it be
Rs 1200, can it be Rs 1300, can it be Rs 500 or Rs 400? What is the
probability of the asset reaching those prices? I think the riskiest assets
bought now can give you the greatest return provided you have the risk
appetite, patience and it’s your own, not borrowed, capital,’ he told Sanjay
Pugalia in an interview on CNBC Awaaz. Rakesh’s bullishness on India
rested on India’s young population (favourable demographics) compared to
other markets like the US, Europe and Japan and on India’s low per capita
income, which provided much scope for catching up to advanced
economies. It was a difficult time to be bullish in 2002. The bull market
didn’t really gather steam till 2004. An investor looking back even in
January 2005 would have seen a decade of just 5 per cent returns on the
Sensex. ‘The past decade has not been good,’ Rakesh noted in an interview
with NDTV in January 2005. ‘Over the next five–ten years, the best
investable asset would be equity. The thing that can disrupt this is the world
economy such as the US or a hard landing in China,’ he told the interviewer.
‘The growth we’ve had in the NIFTY in the last ten years will be far
exceeded in the next ten years. Most of us are attuned to the thought that
this country cannot improve. We cannot grow at 10 per cent. We can’t have
a responsive administration. I think that will change. When I was doing my
CA, we had a 95 per cent rate of income tax. Nobody thought income tax
rates would go below 75 per cent. Now we have a 30 per cent rate of
income tax,’ he told Shereen Bhan of CNBC-TV18 in 2014 after the Modi
election victory. ‘India will see growth greater than China. We all will be
surprised by the kind of growth that will come, Mr Modi will be the
instrument of change but the change will be incremental,’ he added.
According to Shankar Sharma, an investment guru and broker, some of
Rakesh Jhunjhunwala’s enthusiasm was simply a result of not having seen
the world. Rakesh rarely travelled outside India or even outside the city of
Mumbai. This insularity, somewhat counterintuitively, actually burnished
his confidence in the country, according to Sharma.
Rakesh’s optimism about India’s growth was paired with his optimism
about the returns on Indian stocks in the long run. There were moments of
doubt, but these were quickly reversed. When the Covid-19 pandemic hit
India, Rakesh became bearish for a while. ‘I sold 2 per cent of my portfolio
in March 2020 but in April–May, I changed my view and I took on the
highest leverage of my life. The biggest bull market lies ahead of us,’ he
told Shekhar Gupta of ThePrint in a 2021 interview. Rakesh’s optimism also
transcended his political sympathies. ‘I’m a patriotic Indian but I don’t mix
business with patriotism or business with pleasure,’ he added in the same
conversation with Shekhar. In various public pronouncements, Rakesh
spoke approvingly of the Modi government. ‘Mr Modi should lead this
country for the next ten years,’ he told Shereen Bhan in an interview with
CNBC-TV18 in 2014. However, he continued to maintain that his
confidence was not related to any particular government being in power.
While speaking to the authors of this book, Shankar Sharma reiterated that
this was Rakesh’s best quality. ‘Rakesh was extremely bullish on India but
not bullish on any particular political dispensation taking India somewhere.
In the last few years, it’s all become mixed up, politics and investing, which
I think is absolutely dangerous. Every pursuit is a completely independent
pursuit, and you don’t get involved in analysing a country necessarily
through its politics. I say this goes for Harshad Mehta and Rakesh. They
remained bullish on the whole India story itself. In Harshad’s time we had
Congress, then we had the United Front and then we had the NDA. I find
that is a big lesson to all investors that don’t get mixed up with your
political inclination,’ he said.
Similarly, he was not bullish on all sectors and stocks. He knew what
would perform and what would not. While he believed in the broader
growth story of India, he stayed away from a few spaces that he felt would
not be rewarding. Rakesh did not extend his forever bullish view to tech
stocks such as e-commerce, one of the most loved segments among retail
investors in bull phases such as the late 1990s, 2014–15 or 2021–22.
Speaking at the Economic Forum for India at the London School of
Economics in 2015, Rakesh argued against this segment. ‘We don’t have to
participate in every party. Pets.com burnt 500 million dollars in the last
phase of the internet boom. I think e-commerce will grow more than what
you expect but I don’t want to buy these companies. Forget the valuation,
where is the complete business model? I want to know Flipkart’s business
model. You want to lose 250 million dollars a year, where are you going?
Where are the cash flows going to come (from)?’ he asked. He was also
cautious on ‘flavour of the day’ stocks such as private-sector banks in 2015.
His optimism rested on India being a democratic country that is open to
accepting change and is tolerant. ‘Democracy slows us down but it keeps it
together. Look at the list of large-sized developed countries, which have
prospered over the last fifty years or so. They have one quality in common,
that is, they are all democratic. Anything can happen in a dictatorship …
Indian democracy is maturing,’ he said at a FLAME lecture in 2009.
He believed in Indians’ skill of making the most of opportunities. ‘In
1966–67, the government passed an order that GlaxoSmithKline (now
GSK) and other multinational companies have to manufacture APIs in
India. So they set up plants in India. That was the end of it. Now India is a
leading manufacturer of APIs in the world. Now we are making it cheaper
than foreigners. We have made atomic bombs indigenously. We haven’t
stolen technology from anyone. We have launched space satellites for
Israel. We do it at 5 per cent cost at which NASA does it. We are a tolerant
and skilled society with entrepreneurship in our culture,’ Rakesh said in the
same 2009 FLAME lecture.
Demographics are also playing in our favour. ‘Every society goes
through demographic evolution. For the next forty years, India is going to
be among the most favourable demographic profiles of any substantial
nation in the world. This cannot be reversed. All societies that have had the
greatest prosperity have gone through this cycle. China is going to lose it
fast due to their one-child policy,’ he added. Rakesh observed these trends
in 2009, and these views are relevant even today.
Fast forward to today. Rakesh’s investment in India’s newest airline,
Akasa Air, is another testimony to his belief in India’s growth story.
Renowned billionaire entrepreneur Richard Branson has famously said, ‘If
you want to be a millionaire, start with a billion dollars and launch a new
airline.’ Many tycoons, from Vijay Mallya in India to Tony Fernandes in
Malaysia, have lost their fortunes in airline businesses. Airline companies
are hardly profitable. Even Warren Buffett sold all his airline stocks—
United Airlines, American Airlines, Southwest Airlines and Delta Airlines
—as all were in losses in 2020. Rakesh Jhunjhunwala, however, took a
contrarian call by investing $200 million for 46 per cent stake in Akasa Air.
‘Many people ask me why I have invested in an airline. I tell them that I am
prepared for Akasa Air to even fail, but better to have tried and failed than
not tried at all,’ he said at an industry event in February 2022. ‘I hope to
prove people wrong. Now it’s become a matter of ego,’ he added.
Rakesh was last seen publicly at the launch of Akasa Air before he
breathed his last. He confidently announced in interviews that being a
frugal airline, Akasa Air would be very competitive in the aviation space.
‘India’s per capita discretionary expenditure will keep growing, so will
the demand for flights. Therefore, there will be a lot more flights. Ministry
for Civil Aviation has predicted that in four years, we’ll go from 14 crore to
40 crore passengers flying a year. What does it mean? We need two-and-a-
half times more aircraft every year. India’s aircraft fleet size requirement
will almost double by 2027 and it will need 1200 aircraft,’ Rakesh said in
an interview with CNBC-TV18 in August 2022.
What Rakesh believed is for all to see. The world is staring at a recession
in which developed economies such as the US and Europe might log
negative growth, but India is expected to grow at 6–7 per cent in FY23 and
FY24, going by estimates from different agencies. In October 2022,
international investment banker Morgan Stanley came out with a report
saying the next decade belongs to India. It says that the four global trends of
demographics, digitalization, decarbonization and deglobalization are
favouring the New India, which is estimated to drive a fifth of global
growth through the end of this decade. ‘India has the conditions in place for
an economic boom fuelled by offshoring, investment in manufacturing, the
energy transition and the country’s advanced digital infrastructure. These
drivers will make it the world’s third-largest economy and stock market
before the end of the decade, we estimate,’ says Morgan Stanley in its
report titled ‘The New India: Why This is India’s Decade’.
Not very long ago, in 2021, Rakesh said, let alone the decade, the next
century belongs to India.
‘India has got some inherent qualities required for growth. We as a
society have to tap those qualities and enable our citizens for growth. In the
last three to four years, the reforms that have taken place in the form of Jan
Dhan and the way Indian society has digitalized, ease of doing business and
privatizing public sector companies are all going to lead to double-digit
growth in India. India evolves and whatever evolves is permanent. India’s
growth is not top-down but it’s all bottoms-up. I have the same views about
India today as I had ten years ago and what I will have till the day I live … I
don’t know if most Indians are recognizing our country’s potential, but at
least Indian markets are recognizing it,’ he said, addressing a gathering at
the India Economic Conclave 2021.
In the same interview, the anchor, Nikunj Dalmia, asked Rakesh: ‘If the
ongoing bull market is on a train journey from Churchgate to Borivali, then
where has the bull market reached?’ ‘It has reached Charni Road, which is
the very next station after Churchgate,’ Rakesh responded in a jiffy. What
he implied was it was just the beginning of the bull market. Even in 2021,
he knew the bull market would continue. Despite short-term hiccups due to
the Russia–Ukraine war, the rout in global tech stocks and rate hikes by the
US Federal Reserve and other central banks, the Indian markets hit a fresh
high in November 2022.
Chapter 13
The stock market is a place to make quick bucks. Right or wrong, this is a
common perception. No wonder most people come here with a mindset to
get rich quickly. They enter the market to trade, not to invest. Here lies the
catch. Rakesh Jhunjhunwala didn’t earn his fortunes through trading alone.
It did play an integral role in him collecting money in the initial days, but
the real wealth he accrued by investing the trading profits in quality stocks
for the long term. Learning the tricks of the ‘trade’ is not an easy job, but
investing is. The first and foremost principle of investing is having patience
and a long-term outlook. One cannot be a great investor if one always
thinks about buying and selling different stocks.
Jhunjhunwala was a visionary man since the early days, says a family
friend who has known him since the late 1980s. ‘He did tell many of us to
take positions in Titan and CRISIL, but only he had the vision to hold it for
years. He could see its long-term potential and stood by it,’ he said. Rakesh
began investing in Titan Industries in the late 1980s, far earlier than the
popular narrative of him buying the stock in 2002. Time and compounding
powered returns not just in Titan but also in the overall portfolio. Rakesh set
foot in the stock market in 1986. He is fabled to have begun with Rs 5000
in his pocket. His portfolio attained a value of approximately Rs 35,000
crore in 2022, at the time of his death. Some estimates put this value a lot
higher. Debashis Basu put the worth of Rakesh’s portfolio at Rs 50,000
crore in an article in Moneylife.1
***
Rakesh built his capital through trading in the initial stages of his life in the
stock market. He did not start out with family money, nor did he have any
intention to manage a fund or corpus for a third party to earn capital. He
had no option but to trade and take leverage (borrow money) in order to
take large bets on stocks. Leverage capital amplifies your buying power in
the stock market, and that helps you make big money. How does leverage
work? Let’s understand leverage and non-leverage trading. Suppose you
have Rs 2,00,000 to invest in stock A, whose spot price and futures price
are the same, at Rs 400. You can take the following two actions:
In the first situation, you will be able to purchase 500 shares of stock A.
Now if the stock price goes up from Rs 400 to Rs 450, you will end up
earning profits to the tune of Rs 25,000, a jump of 12.5 per cent. If the price
drops to Rs 350 from Rs 400, then the losses you incur will stand at Rs
25,000.
Coming to the second situation, in the derivatives market, the futures are
sold in lot sizes. Assume stock A has a lot size of 1000 shares. The contract
value of one lot size will be Rs 400 * 1000 = Rs 4,00,000.
But you only have Rs 2,00,000 available with you. The beauty of the
futures market is leverage trade, which is also known as margin trade. Your
broker may provide you leverage (margin money), in which you only have
to keep some margin with the broker. Suppose it is 30 per cent of the
leverage. Now you only have to pay 30 per cent of Rs 4,00,000, which is Rs
1,20,000, to buy one lot of stock A futures. If the price moves from Rs 400
to Rs 450, you will make Rs 50,000 profits. You may have taken a bet on
Rs 4 lakh but essentially, you invested just Rs 1.20 lakh to earn Rs 50,000
in profits. Your return on equity thus is 41.66 per cent (50,000/1,20,000).
This is much better than what you could have earned in the cash market.
Leverage thus amplifies your returns faster.
Trading with borrowed capital, however, is extremely risky. What if your
trading call goes wrong? You will have to make up for the losses on the
entire capital of Rs 4 lakh.
Rakesh Jhunjhunwala had set a rule for himself. ‘Sar salamat to pagadi
hazaar’—Rakesh would often quote this one-liner. It means, better to
sacrifice a little pride to save your life. He would never get emotionally
attached to his trading bets. If his trading call went wrong, he would accept
the loss and settle the trade the same day. It means that whatever he owed to
his debtor, he would pay off and close the matter the same day. This ability
to take losses made him the astute trader that he was. He would pay off the
lender even if he suffered mark-to-market losses. ‘He would tell us, never
let lenders sit on our heads. It will affect you emotionally and may cripple
your judgement during market hours,’ says one of Rakesh’s ex-employees.
‘Most people feel ashamed if a trading call goes wrong, but Bhaiya was
cut from a different cloth. He never cared about being right or wrong. His
goal was to make money,’ the ex-employee says.
‘Whatever I have learnt in the stock market, I owe it to him. One of the
finest lessons that I have learnt is when to scale up and down in trading.
Bhaiya has a calculator in his mind. Mentally, he would fix a threshold of
the leverage. If it went past it, he would ruthlessly sell. For example, if he
was playing with Rs 10,000 crore, and he lost Rs 200–300 crore, he
wouldn’t care about his outlook on the stock. He would first sell and think
about the next move later. Even if it seemed that the market would go up
tomorrow, he would still sell.’
With all the money that he had, Rakesh could easily hold on to his loss-
making trading bets and wait for them to make good, but he preferred to
book losses rather than wait to flip the situation. In contrast, most people
take on more leverage when they are making losses. This is a cardinal
mistake.
Rakesh had tasted early on how borrowed capital may ruin one’s fortunes
in the stock market. In the early 1990s, during the first-ever bull market
after the 1991 reforms, Harshad Mehta emerged as the poster boy of the
stock market. Rakesh and Radhakishan Damani were still among the rookie
traders under the patronage of Manu Manek, a big bear (someone who
profits from a fall in stock prices) who was nicknamed Cobra. The bear
camp believed that the exorbitant rally in the stock market was
unwarranted. They dared to start selling shares in which Harshad was most
active, such as ACC, Apollo Tyres, Mazda Industries, Karnataka Ball
Bearings and Scindia Steamships, among others. At the onset of 1992 and
after a great Budget by then Finance Minister Dr Manmohan Singh (when
he opened up the economy to foreign investors), the markets were on fire,
as if there were no tomorrow. The Manu Manek-led bear camp started
selling stocks that they felt Harshad Mehta had artificially inflated. This is
called short-selling, that is, selling shares that you don’t own, anticipating
the prices of the share will fall in the future. Once that happens, they can
buy at a lower price and make delivery at a later date. What if the share
doesn’t fall and the settlement day for delivery arrives? If the seller cannot
deliver shares, they need to pay undha badla (consideration for roll-over) to
the buyer to roll over the delivery to the next settlement day. This is a
unique situation in which the seller has to pay the buyer.
As the prices of Harshad Mehta’s counters kept rising, the bear camp
continued paying undha badla through borrowed capital. Rakesh would tell
his friends later, had the rally continued for another couple of days, the bear
camp and he would have been out of the market. It was purely luck, not
skills, that saved the day for the bear camp. The first week of April 1992
was a life-and-death scenario for Rakesh. Luckily, the same week, journalist
Sucheta Dalal broke the news about missing banker receipts from the State
Bank of India. The defaulter was none other than Harshad Mehta. His
counters, which the bear camp had short-sold, fell like a house of cards.
Finally, they made money. This was one of their biggest jackpots. However,
it did teach Rakesh to eat only what he could digest. They did the same in
Dhirubhai Ambani’s Reliance Industries in 1997. This time, they were
unsuccessful. Dhirubhai Ambani won the battle while the bear camp
decided to cut their losses.
Such risky trades taught Rakesh to manage his leveraged bets. He made a
rule to bear losses and settle the dues with his financiers before the new
trading day began. He stayed away from excessive leverage and taking
undue risks.
One of his friends has an interesting story to share about the discipline he
followed in leveraged bets. ‘Once, he asked me to buy shares of Tata Tea
(after the 1992 scam). I had only Rs 12,000. He warned me not to go
overboard on leveraging. However, I went overboard against RJ’s advice. I
did make a profit of Rs 20 lakh (on Rs 12,000) by excessive leverage, but
when I told Rakesh about this, he furiously told me to stay away from such
risks. His point was to make money within limited risks. “Sattebaji na kar
(do not gamble)”—that’s what he told me,’ the friend shares the anecdote.
Rakesh’s friend made money on his suggested bet, but Rakesh didn’t
appreciate the way he did it. He took more risk than what was warranted.
Nothing negative happened to the friend in this case, but he advised him to
follow the rules. He preferred following a discipline in trading—knowing
how much leverage to hold and when to exit. That is how he managed risk
in leveraged trading.
According to investment guru Shankar Sharma, while speaking to the
authors of this book, it is trading that built Rakesh’s skill and these skills are
something that managers of third-party money never quite develop. ‘The
pursuit of trading itself makes you a very rounded investor. You need that
knowledge. If you’re only an investor or managing money, you don’t get to
understand that. Ram Jethmalani was the greatest lawyer that the world has
seen and probably will ever see. And I asked him once, what made you
what you are? He replied that it’s not that he’s more intelligent than others
but that he worked his way up by arguing criminal cases from the lowest
court. According to Jethmalani, a criminal case in a lower court is not about
law, it is about facts. What time did the accused leave, what colour shirt was
he wearing—the lawyer needs to focus on minute details and this helped
Jethmalani even while arguing a high-profile constitutional matter.’
According to Sharma, ‘Think of trading as being exactly that. There is an
immediate feedback loop—at 3.30 p.m., you have a mark to market, which
means you’re extremely, extremely focused on the entire jigsaw of the
market; you cannot afford to ignore anything.’
Rakesh’s trading strategy was diametrically different from the ‘buy low
sell high’ adage applied to investing. Rakesh would buy stocks that were
trending or seeing momentum behind them, even if that meant buying at
higher prices. Conversely, he would get out of stocks that were trending
lower, even if it meant taking a loss. He fleshed out this thinking in a
conversation with Ramesh Damani, broadcast on CNBC-TV18 in 2010–11.
‘See, Ramesh, we don’t initiate more than 40 per cent of trades that turn
out to be right. We do what I call pyramiding. I buy a stock at Rs 100, I buy
more at 105, I buy more at 110. So what is trading? It is basically
momentum. You play with momentum. If the market is rising, buy on the
rise. If markets are going down, you sell in the fall. This applies to short-
term, medium-term and long-term trends. If you average a losing trading
position, it is at your own cost. At least, I never do that. Suppose a stock is
at 90 and I feel it’s going to have a big upside and the fall is 4–5 per cent, I
might average. As a rule in trading, I will never average. A good trader
should have his highest position outstanding at the highest price. Who
knows what is the highest price?’ he said. According to Rakesh, that’s why
out of one million, only ninety or a hundred make money.
The bull market of 1992 during the Harshad Mehta days was not the only
occasion when Rakesh was on the brink of losing it all in his trading calls.
Another such occasion came ten years later, in 2002, when he turned
prematurely bullish on the stock market. According to Sharma, Rakesh was
in a tough spot in that year. ‘There was a setback in June 2002. I had to
liquidate 25 per cent of my portfolio in four days. But I did that, I honoured
everything. When the markets turned favourable again, I leveraged again,’
he said in a conversation with Ramesh Damani on CNBC in 2020.
Success in trading is inextricably connected to limiting one’s losses in
losing trades because not all trades will work out, even for the best traders.
‘Know how to take a loss. Nobody can predict momentum. All big moves
start with small moves. The price is the first indicator of what is coming. If
I buy a stock at Rs 100, if it goes to 120, I buy more. If it goes to 90, I’m all
squared up. I can’t sleep, I can’t eat, I have unease. Not every year I make
money. I make money in spurts, like 1989–92, 2003–07, 2009–11. In the
years 1994 to 1999, I would not have made any trading companies,’ Rakesh
added in his conversation with Damani. The need to control losses is
particularly important because trading is largely funding by debt
(borrowing). This applied to Rakesh Jhunjhunwala as well. ‘We are not
employing millions of dollars in trading. My net capital employed in
trading is Rs 1 lakh. Everything else is borrowed. I borrow money against
my and my wife’s assets,’ he told Damani.
Rakesh drew a sharp distinction between trading and investing. ‘How do
you find value in a stock? For every buyer, there is a seller. Some like
Nandita Sen, some like Sushmita Sen, some like Aishwarya Rai. When you
think of buying a stock, think of the business model. I’m talking about
investing here, not trading. Would I have invested in Titan if I had not felt
that the branded jewellery market in India will go from 5 per cent to 20 per
cent? In five years, if 1 lakh crore is going to be the jewellery market in
India, the branded jewellery in India will go from 5000 crore to 20,000
crore,’ he told students at a lecture at FLAME University. Rakesh went on
to elaborate what he meant by opportunity. ‘When you look at the
opportunity, look at the addressable opportunity. In infrastructure, the
opportunity is huge, but if my company can only make water pumps, that’s
not good enough. The unknowns—to make them known is difficult,’ he
said.
According to Rakesh, another major difference between trading and
investing is the concept of ‘averaging down’. When the price of a share that
you have bought falls, should you buy more at a lower price?’ Rakesh
answered this question at a Moneybee event in 2016. ‘When you are
trading, never average. Trading is about momentum. When you are
investing, you can average. I have done so at times,’ he said. When a stock
moves against you in a trade, it means that the momentum is against you. In
such a situation, averaging out your price can only compound your losses.
In this situation, accepting the loss and getting out of the trade may be a
smarter strategy. ‘Small investors and those who do not have a deep
understanding of the market should stick to mutual funds. If you want to
invest in both mutual funds and direct stocks, allocate 95 per cent of your
portfolio to mutual funds and only 5 per cent to stocks. Invest through SIPs
because it is difficult to time the market,’ he added.
In trading, he advised catching the momentum. He would always say,
‘Trading is vadhare vadhare, levanu; ghatade ghatade, vechvanu (buy more
if it’s going up; sell if it’s going down).’ One has to be emotionless in
trading bets. If a trading bet moves against your expectation, you accept the
loss and move on. Respect the momentum.
‘Trading is all about price. You need to have a broad direction of the
market. You need not be an expert about it. You should know when to stake
money and when to take a loss. What happens is, people try to extract too
precise a trend rather than broadly recognizing the trend,’ Rakesh said in an
interview with Ramesh Damani.
In the same interview, Damani asked him if, given a choice, he would
want to be a trader or an investor. ‘I would want to be both. Both have its
own pleasures. Trading profits have greater pleasure though,’ Rakesh
replied.
As far as retail investors go, Rakesh’s advice was nuanced. He felt that
ordinary investors had unrealistic expectations from equity as an asset class
and while looking at stocks, people had a trading mentality rather than an
investing mentality. In an interview with ValueQuest before the 2014
elections, he was asked if ordinary investors should invest in equities. ‘Yes.
I’ll give you a very good example. When you buy an insurance policy from
an agent, what dream does he sell you? Every month you give Rs 5000 and
after a certain number of years, you’ll get a lump sum. 40 per cent of the
first premium goes as commission and after that 4–5 per cent commission.
Why don’t people have the same attitude about equities? People don’t have
realistic expectations. People don’t know that the world’s greatest investor
has compounded wealth at 22 per cent,’ he said. ‘Trade is for creating
capital, investing is for growth. In trading, the risk is extreme. Most people
think they are investing but, in their mind, they’re thinking about trading. If
the return in other asset classes is 10–11 per cent, equity can give you 18
per cent. If I get 18 per cent, I’m a king, if I get 22 per cent, I’m an
emperor. You get much greater returns than insurance. In 2002, I used to
catch people on the road—sell your wife’s bangles and buy equities
(meaning that equities are so attractive, sell your wife’s bangles if you need
to, to find money to invest)—but nobody used to buy. If you want to trade,
don’t mix it with investing,’ he said.
Chapter 15
Be an original thinker
To the people who followed his portfolio, Rakesh was categorical. ‘You
cannot make money on borrowed knowledge. Please understand what I’m
saying and my thought process instead. Let me give you an example. I
bought Sterling Holiday Resorts at 75 rupees. The stock immediately went
to Rs 120 and now it is languishing at Rs 80. Those poor people have lost
money. I personally have a five-year or seven-year time horizon, you
haven’t. I have a risk appetite that is much larger than yours. Don’t try and
do what I’m doing,’ he told the interviewer at ET Now on 2 October 2012.
Consistency is key in the investment world and it comes only with one’s
conviction. ‘Rakesh would never shy away from sharing his stock ideas
with others. This is even when most of us, including R.K. Damani and
Nemish Shah, would tell him not to. He would offer stock tips to even those
who would come to him at Geoffrey’s, where he would often go to hang out
after market hours,’ says Rakesh’s trader friend.
Rakesh Jhunjhunwala called himself an open book. He couldn’t have
changed his character. He anyway knew that just knowing the stock idea
was not enough. When to exit is equally important. The person who has
suggested the stock idea will most likely make the smart exit, but he won’t
come back to tell you to do the same. This is the reason why investing on
borrowed knowledge doesn’t work. Sometimes Rakesh’s views wouldn’t
gel with his friends R.K. Damani’s or Nemish Shah’s, but he would stick to
his thought process. He would never get influenced.
Every Jhunjhunwala follower wants to learn how he picks his stock bets.
This is what he has to say about it: ‘Stock market investment cannot be
taught. It has to be learnt.’ It’s not that he has never discussed his stock-
picking mantra. It’s about how well you receive the crux of it—more
importantly, how you are going to practise it. There are five aspects which,
according to Jhunjhunwala, should be followed to pick multi-bagger stocks:
ii) Opportunity
Second, one needs to assess the market opportunity as to how big an
opportunity the company is looking at as its market size grows. The
opportunity and market size should move in tandem. This is what provides
a long runway for growth. There has to be a big change or a turnaround
happening. The greatest wealth is earned when change happens, Rakesh
would say. The business model should have entry barriers.
Leveraged trading
Rakesh would borrow money to invest in the market so that he could take
large positions for larger profits. While he could manage his debt, he never
advised others to follow this approach. Investing in the stock market on
borrowed capital is one of the sure-shot ways to get poorer. In fact, in his
keynote address to students at FLAME University in 2009, he talked about
his wish to reduce his debt. ‘I want to get deleveraged, but hota nahi hai
(it’s hard to do it). If I have bank balance, I can’t sleep well. If I pay
interest, then only I get good sleep,’ he says.
It had become a habit for Rakesh to invest on borrowed capital and pay
interest. In fact, in one of his interviews with Ramesh Damani, he claimed
that he had deployed only Rs 1 lakh in trading; the rest was the borrowed
capital. He boldly claimed often that he earned his wealth from the long-
term investment through trading. Rakesh’s story may inspire you to do the
same. However, it is not meant for all. For him, it was a passion. This is
what he did, thought and talked about all the time. He mastered it. A regular
investor, whose primary job is different, will not have the time and the
mindspace to emulate Rakesh’s trading style.
For retail investors, borrowing to trade is not a great strategy. The market
can be irrational in the short run, longer than you can stay solvent—even if
you’ve made the right bets. Leverage forces you to either book a profit or
get out of a trade in the short run. Without leverage, what would your
returns have been? Let’s understand with an example of the Sensex. A sum
of Rs 561 invested in the Sensex from 1986 to 2022 would have become Rs
59,842 on 16 August 2022. But most people get regular monthly income
from a salary and they tend to invest every month through an SIP rather
than starting off with a lump sum amount and never adding to it. So if you
had set up a simple SIP of Rs 5000 per month in the Sensex over this
period, it would have built a corpus of Rs 6 crore. If you had increased this
SIP by 10 per cent every year, the money would have grown to 13.1 crore.
Do these amounts seem low to you? You may know middle-class families
who have built much more wealth than this by investing similar amounts
twenty or thirty years ago in plots of land or flats. However, the secret to
their fortune is also the same as Rakesh Jhunjhunwala’s—leverage of debt.
The typical home buyer would put down 20–30 per cent of the cost of the
property as down payment and pay off the rest. This increases your starting
capital. Let’s assume that you bought a house for Rs 20 lakh in 1993 and
put down Rs 5 lakh of your own money and borrowed the rest from a bank
(Rs 15 lakh). The value of this house grows at a rate of 12 per cent over the
next thirty years and your interest rate over the same period is 10 per cent.
The value of this house would now be Rs 6 crore. Even adjusting for loan
repayment with interest (a total payment of Rs 47 lakh if you had opted for
thirty years), this value is much higher than a stock portfolio that grows at
12 per cent over the same period. A stock portfolio of Rs 5 lakh growing at
12 per cent over thirty years would attain a value of 1.5 crore. Why did this
happen? The loan of Rs 15 lakh acted as a magnifier—it pushed up your
overall wealth creation. However, leverage is by no means a good thing. A
problem with the underlying asset—let’s say a land dispute in the case of
real estate or an undelivered flat—can send leverage into reverse,
magnifying your losses rather than your profits.
Legendary investor Warren Buffett once said, ‘When you combine
ignorance and leverage, you get some pretty interesting results.’ Leverage,
if used well, magnifies your gains, but if used carelessly, it can magnify
your losses dramatically. Losses not only affect your financial health but
also devastate your mental wealth. One needs to be in sync with one’s
psychological behaviour to master trading. Even Rakesh would sometimes
get frustrated if a trading bet worked against him. He was known to have
thrown objects around, breaking glass tables and televisions if he incurred
huge losses in trading. It’s hard to maintain your calm seeing losses in your
book. It makes you err more.
‘Leverage is like a personal habit of smoking and drinking. If done in a
measured manner, it’s a pleasure. If overdone, it’s a problem. It has to be
emotionless. If it goes against you, nobody will come to help you,’ says
Rakesh in one of the TV interviews.
The timing of the leverage matters a lot as well. Not all can get it right.
‘In 2002, even though I was extremely bullish on the stock market, I still
sold 25 per cent of my portfolio in four days to reduce my leverage because
one never knows what may happen. So get it right—there are times when
you should leverage and when not … even though I had much more wealth
in 2008 compared to what I had in 2003, the leverage in 2008 was not even
10 per cent of what I had in 2003. Timing and valuations matter,’ Rakesh
explained in an interview.
He often said that if things went against one’s expectations, then it was
better to square off and sit at home. The crux is to never let leverage control
your trade. You control your leverage; the leverage should not control you.
If one can master this art, one has arrived in trading the way Rakesh did.
Small-cap bias
Rakesh Jhunjhunwala excelled at picking companies at the initial stage of
their growth cycle. That said, he had a small-cap bias in his approach to
picking stocks. More than 5000 companies are listed in the stock market.
The large-cap stocks, comprising the top 100 in terms of market
capitalization, are known to all and are well-researched. The next 150
stocks, between 101 and 250, are mid-cap stocks. Stocks having a ranking
of 251 and beyond in terms of market capitalization comprise the small-cap
universe. This is the segment where the magic happens. Rakesh was smart
enough to pick quality stocks from the small-cap basket. He latched on to
Titan, CRISIL and Lupin when these stocks were small-cap companies. ‘It
doesn’t take me much time to make an investment decision. I can do it in
ten minutes. I don’t buy all positions in one go. I buy some, wait to see how
the company performs, research more and then I increase my holdings,’
says Rakesh.
A regular investor would do well to stay away from the small-cap
universe as a beginner. The volatility in small-cap stocks may not let most
investors sleep. Rakesh had a long-term vision and conviction in his stock
picks. Even if a stock fell by 50 per cent, he would hold on to it if he was
convinced that the fundamentals hadn’t changed. Doing that may not be
easy for a regular investor. If one wants to find multi-baggers from the
small-cap universe, one has to spot it themselves. Only then can one have
the discipline and belief to hold it for the long term and bask in its
profitable glory.
One may feel that Rakesh had undue access to information that made him
take informed calls when it came to stock picks. Rakesh categorically
denies it. According to him, there is no information asymmetry in the
market. ‘Tamil Nadu state government offered to sell 25 per cent stake in
Titan but Tatas didn’t buy it. The truth is some of my finest investments are
in companies where even management didn’t have the confidence or vision
that they will grow so much.’ Titan is a joint venture between Tata Group
and the Tamil Nadu Industrial Development Corporation Ltd.
Rakesh has said in different interviews that promoters of small-cap
companies would come to him and tell him to ‘manage’ the price. ‘They
will say, the stock is at Rs 70, we shall give it to you at Rs 40. If you buy it,
more people will follow you. This is how we’ll take the prices upwards.
Then you sell it. The kind of money such a scheme can make is humongous,
but means are important. I would tell them I know the way to Arthur (Road)
Jail. Don’t tell me how to reach there,’ he said.
Murky deals, price manipulation and forged financial results are all too
common in the small-cap universe. Most of these companies do not even
conduct earnings calls after the quarterly results. One has to invest in such
companies with a pinch of salt. Finding gems in this space is not an easy
task. It is better to leave it to the fund manager. Investing in a small-cap
mutual fund would be much safer than picking small-cap stocks on one’s
own.
Chapter 7: CRISIL
1 Mudar Patherya, ‘Remembering Rakesh Jhunjhunwala: There Was No
Moderation in His Existence,’ The Economic Times, 14 August 2022,
https://economictimes.indiatimes.com/markets/stocks/news/remembering
-rj-there-was-no-moderation-in-his-existence/articleshow/93557908.cms?
utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
2 Hemanth Gorur and Sumit Chowdhury, Doing What Is Right: The CRISIL
Story, 10 December 2012.
3 Rajesh Mascarenhas, ‘5 Stocks and the Making of the Legend of Big
Bull,’ The Economic Times, 15 August 2022,
https://economictimes.indiatimes.com/markets/stocks/news/five-stocks-
and-the-making-of-the-legend-of-big-bull/articleshow/93566657.cms?
utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
Chapter 8: Lupin
1 Disruption Series, Vol. 12, Pharmaceutical Industry, Ambit Capital, April
2021, p.2,
https://www.ambit.co/public/thought_leadership/Ambit_Disruption_VOL
12_Pharma.pdf
2 ‘Our Story’, from the Lupin website, https://www.lupin.com/about-
us/our-story/
3 Lupin annual report—
https://www.bseindia.com/bseplus/AnnualReport/500257/73654500257.p
df
4 Shalini Rath, ‘Lupin Limited | Success Story of Becoming a Multinational
Pharma Company’, startuptalky.com, 19 October 2022,
https://startuptalky.com/lupin-success-story/
5 S.P. Jain Institute of Management and Research, ‘Dr. Kamal Sharma of
Lupin Limited is Executive-in-Residence at SPJIMR’, prnewswire.com,
2 December 2016, https://www.prnewswire.com/in/news-releases/dr-
kamal-sharma-of-lupin-limited-is-executive-in-residence-at-spjimr-
604219466.html
6 Suprotip Ghosh, ‘K.K. Sharma’s Skills Have Steered Lupin into Big
Pharma League’, Business Today, 5 January 2014,
https://www.businesstoday.in/magazine/cover-story/story/india-best-ceo-
2013-pharma-kk-sharma-lupin-success-42614-2013-12-23
7 Disruption Series, Vol. 12, Pharmaceutical Industry, Ambit Capital, April
2021, p.2,
https://www.ambit.co/public/thought_leadership/Ambit_Disruption_VOL
12_Pharma.pdf
8 Ibid.
9 Sohini Das, Lupin’s Goa Plant Gets 7 Observations from Usfda, Firm
Unperturbed,’ Business Standard, 19 September 2021,
https://www.business-standard.com/article/companies/lupin-s-goa-plant-
gets-7-observations-from-usfda-firm-unperturbed-121091900777_1.html;
Monal Sanghvi, ‘U.S. FDA Flags Quality Lapses at Lupin’s Goa
Facility’, BQ Prime, 27 September 2021,
https://www.bqprime.com/markets/us-fda-flags-quality-lapses-at-lupins-
goa-facility (As per JM Financial brokerage, it is negative and broadly
speaking, a plant getting repeat observations shows a lax approach to
compliance.)
10 September 2017 Investor PPT of Lupin, Slide 5 titled ‘Is the Indian
Pharma Market Model done? - Current Model Showing Signs of Ageing’,
https://www.bseindia.com/xml-
data/corpfiling/CorpAttachment/2017/9/a537fc59-a539-4b0e-899f-
aa3fdb9785dd.pdf
11 Taken from a report titled ‘India Pharmaceuticals—Favorable risk
reward’ by Vishal Manchanda and Bezad Deboo, published by
Systematix on 20 September 2022.
12 Leroy Leo, ‘Lupin Posts Rs 835 Crore Loss in Oct-Dec on Second Gavis
Impairment,’ Livemint, 6 February 2020,
https://www.livemint.com/companies/company-results/lupin-posts-rs835-
crore-loss-in-oct-dec-on-second-gavis-impairment-
11581001557755.html
13 Harshita Singh, ′Stocks to Watch: ITC, Lupin, Ruchi Soya, Manappuram
Finance, JSW, Biocon′, Business Standard, 19 May 2022,
https://www.business-standard.com/article/markets/stocks-to-watch-itc-
lupin-ruchi-soya-manappuram-finance-jsw-biocon-
122051900162_1.html
14 https://www.lupin.com/lupin-q1-fy2023-results/
Chapter 9: DHFL
1 2001 Annual report,
https://www.bseindia.com/bseplus/AnnualReport/511072/5110720311.pd
f; 2018 annual report,
https://www.bseindia.com/bseplus/AnnualReport/511072/5110720318.pd
f
2 DHFL 29th annual report 2012–2013, https://www.dhfl.com/docs/default-
source/investors/annual-reports/2012-2013/dhfl-ar-2012-13.pdf?
sfvrsn=bde58962_0
3 M.G. Arjun, ‘DHFL Scam | Wadhawan Brothers in Fraud’, India Today,
11 July 2022, https://www.indiatoday.in/magazine/special-
report/story/20220711-dhfl-scam-wadhawan-brothers-in-fraud-1968835-
2022-07-01)
4 ‘DHFL Scam: The Family Accused of the Biggest Banking Fraud Knows
How to Stay out of Jail,’ The Economic Times, 27 June 2022,
https://economictimes.indiatimes.com/industry/banking/finance/banking/
dhfl-scam-the-family-accused-of-the-biggest-banking-fraud-knows-how-
to-stay-out-of-jail/articleshow/92467586.cms?
utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
5 https://www.bseindia.com/bseplus/AnnualReport/511072/5110720319.pdf
6 Aniruddha Bahal, ‘Dewan Housing Finance Corporation Limited—The
Anatomy of India’s Biggest Financial Scam’, 29 January 2019,
https://cobrapost.com/blog/biggest-financial-scam/1373
7 ‘DHFL Scam: The Family Accused of the Biggest Banking Fraud Knows
How to Stay out of Jail’, The Economic Times, 27 June 2022,
https://economictimes.indiatimes.com/industry/banking/finance/banking/
dhfl-scam-the-family-accused-of-the-biggest-banking-fraud-knows-how-
to-stay-out-of-jail/articleshow/92467586.cms?
utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
8 Business Desk, ‘DHFL’s Rs 34,615-Crore Fraud: A Look at India’s
Biggest Bank Fraud Case,’ News 18, 23 June 2022,
https://www.news18.com/news/business/dhfls-rs-34615-crore-fraud-a-
look-at-indias-biggest-bank-fraud-case-5428069.html
9 Arjun, ‘Rakesh Jhunjhunwala’s Fav Mid-Cap HFC Stock Is A Strong Buy
Now: Experts’, rakesh-jhunjhunwala.in, 15 April 2016, https://rakesh-
jhunjhunwala.in/rakesh-jhunjhunwalas-fav-mid-cap-hfc-stock-is-a-
strong-buy-now-experts/
10 Ravi Dharamshi, ‘Rakesh Jhunjhunwala Interview with ValueQuest –
After Rupee Crisis and before 2014 Elections.’ YouTube video, 1:01:15.
19 August 2022. https://www.youtube.com/watch?v=QaWanFCu76M
11 Interim ex parte order in the matter of Dewan Housing Finance
Corporation Limited, 22 September 2020,
https://www.casemine.com/judgement/in/5f86c04c342cca192e7068d2
12 ZeeBiz Web Team, ‘Dewan Housing Goes Tumbling Down, Again!
Guess What! Like Rakesh Jhunjhunwala, Did You Invest? See How Rich
This Stock Will Make Him’, Zee Biz online, 28 November 2018,
https://www.zeebiz.com/india/news-rakesh-jhunjhunwala-dewan-
housing-share-price-dhfl-edelweiss-phillip-capital-did-you-invest-big-
bull-stocks-73401
13 ZeeBiz Web Team, ‘Surprise Gift from Dewan Housing to Rakesh
Jhunjhunwala, Other Investors! Shares Rocket Nearly 8 per Cent on
These Reports’, Zee Biz online, 19 December 2018,
https://www.zeebiz.com/india/news-dewan-housing-rakesh-
jhunjhunwala-stake-dhfl-share-price-8-gain-surprise-gift-for-investors-
mutual-funds-business-stake-sale-76570
14 Anirudh Laskar, ‘Investors to Move SC Against Plan to Delist DHFL
Shares,’ Livemint, 18 June 2021,
https://www.livemint.com/news/india/investors-to-move-sc-against-plan-
to-delist-dhfl-shares/amp-11623955779992.html